基本信息
views: 42
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
My primary focus is the optimization of drug therapy using quantitative models of drug disposition (pharmacokinetics) and action (pharmacodynamics), including physiologically based pharmacokinetic models, to integrate in vitro and in vivo data, leading to better understanding of drug disposition and effect. Patient-specific variables including demographic and pharmacogenetic factors are incorporated into the models to identify individuals most likely to respond to drug therapy or who are at most risk of experiencing an adverse event. Also use physiologically-based pharmacokinetic models to examine changes in drug metabolism and disposition in various populations, including pregnant women and children.
Research Interests
Papers共 166 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Cancerno. 10 (2024): 1858-1868
Maxime Le Merdy,Ke Xu Szeto, Jeremy Perrier,Michael B. Bolger,Viera Lukacova, Karel Allegaert,Sara Quinney,Andre Dallmann
PHARMACEUTICSno. 1 (2024): 96
American Journal of Obstetrics & Gynecology MFMno. 3 (2024): 101304-101304
CLINICAL PHARMACOLOGY & THERAPEUTICS (2024): S106-S106
Cited0Views0Bibtex
0
0
Silpa Gampala,Hye-ran Moon,Randall Wireman, Jacqueline Peil, Sonia Kiran,Dana K. Mitchell,Kylee Brewster,Henry Mang,Andi Masters,Christine Bach, Whitney Smith-Kinnamen,Emma H. Doud,
PHARMACOLOGICAL RESEARCH (2024)
CLINICAL PHARMACOLOGY & THERAPEUTICS (2024): S105-S106
Cited0Views0Bibtex
0
0
M. Kandasamy, T. Richardson, A. Masters, C. Bach, S. Sukoff Rizzo,S. Doolen,S. Quinney, C. Jesudason
CLINICAL PHARMACOLOGY & THERAPEUTICS (2023): S51-S51
Cited0Views0Bibtex
0
0
Proceedings of IMPRSno. 1 (2023)
Load More
Author Statistics
#Papers: 167
#Citation: 2094
H-Index: 24
G-Index: 43
Sociability: 6
Diversity: 3
Activity: 42
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn